Neurodermatitis

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Sanofi-Aventis Recherche & Developpement Commercial
    DUPILUMAB
    2024-514737-37-00 8 countries 2025 n=77
    Recruiting
  • Sanofi-Aventis Recherche & Developpement Commercial
    DUPILUMAB
    2024-514762-39-00 7 countries 2025 n=69
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Sanofi-Aventis Recherche & Developpement Commercial 2 Phase III 1
New trials by year
2025
2
← All indication landscapes